From: "George D. McCallion" <medchem**At_Symbol_Here**COMCAST.NET>
Subject: Re: [DCHAS-L] Butyl Lithium & syringe safety
Date: March 7, 2013 11:48:10 AM EST
Reply-To: DCHAS-L <DCHAS-L**At_Symbol_Here**MED.CORNELL.EDU>
Message-ID: <CAA4EBLtk1T8Dp=FGoE9QpNp67DjzTj2eyKjrnBHYuH7TQ0DGHA**At_Symbol_Here**mail.gmail.com>
Out of the gate, I would suggest going to the DCHAS-L webiste and examine the email database. there is a plethora of email traffic on this; some of which was provided by myself.
In answer to your questions, Kim...
********************************
George D. McCallion
QA Reviewer, Quality and Compliance
QS Pharma, LLC
3 Chelsea Parkway, Suite 305
Boothwyn, PA 19061
Mobile: 610.888.2436
Office: 610.485.4270, ext. 245
George.McCallion**At_Symbol_Here**qspharma.com
From: "Kim Gates" <kim.gates**At_Symbol_Here**STONYBROOK.EDU>
To: DCHAS-L**At_Symbol_Here**MED.CORNELL.EDU
Sent: Thursday, March 7, 2013 9:52:50 AM
Subject: [DCHAS-L] Butyl Lithium & syringe safety
I have a question from our Chem dept about nButyl Lithium & syringes after I forwarded them the CEN blog on safer syringes. http://cenblog.org/the-safety-zone/2013/02/engineering-safer-syringes/
Previous post | Top of Page | Next post